IIM
UTHR icon

INTECH Investment Management’s United Therapeutics UTHR Stock Holding History

INTECH Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
29,102
+8,358
+40% +$4.71M 0.14% 116
2026
Q1 		$12.3M Sell
20,744
-2,779
-12% -$1.38M 0.12% 148
2025
Q4 		$11.5M Buy
23,523
+4,020
+21% +$1.87M 0.1% 166
2025
Q3 		$8.18M Sell
19,503
-12,553
-39% -$4.22M 0.07% 239
2025
Q2 		$9.21M Buy
32,056
+1,121
+4% +$335K 0.09% 198
2025
Q1 		$9.54M Buy
30,935
+442
+1% +$151K 0.1% 173
2024
Q4 		$10.8M Buy
30,493
+22,205
+268% +$8.16M 0.1% 158
2024
Q3 		$2.97M Sell
8,288
-6,815
-45% -$2.3M 0.03% 373
2024
Q2 		$4.81M Sell
15,103
-4,309
-22% -$1.14M 0.06% 261
2024
Q1 		$4.46M Buy
19,412
+18,476
+1,974% +$4.17M 0.06% 249
2023
Q4 		$206K Sell
936
-1
-0.1% -$230 ﹤0.01% 679
2023
Q3 		$212K Sell
937
-1,908
-67% -$439K ﹤0.01% 691
2023
Q2 		$628K Sell
2,845
-1,184
-29% -$262K 0.01% 551
2023
Q1 		$902K Buy
4,029
+1,235
+44% +$304K 0.01% 532
2022
Q4 		$777K Hold
2,794
– – 0.01% 552
2022
Q3 		$585K Sell
2,794
-4,660
-63% -$1.04M ﹤0.01% 574
2022
Q2 		$1.76M Buy
+7,454
New +$1.52M 0.01% 469

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

INTECH Investment Management's UTHR Position: Q2 2026 in Review

INTECH Investment Management increased its United Therapeutics (UTHR) stake by 40% in Q2 2026, buying an estimated $4.71M and bringing the position to 29,102 shares worth $15.8M. The position accounts for 0.14% of the portfolio, ranked #116.

INTECH Investment Management first reported a position in UTHR in Q2 2022 and has held it in 17 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • INTECH Investment Management held 29,102 shares of United Therapeutics worth $15.8M as of Q2 2026.
  • INTECH Investment Management bought 8,358 United Therapeutics shares in Q2 2026, an estimated $4.71M.
  • United Therapeutics made up 0.14% of INTECH Investment Management's portfolio in Q2 2026, its #116 holding.
  • INTECH Investment Management first reported a position in United Therapeutics in Q2 2022 and has held it in 17 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.